Dr Rachel Dear

MBBS (Hons 1) PhD FRACP
Medical Oncologist and Senior Lecturer
Central Clinical School

Telephone +61 2 9351-6171
Fax +61 2 9351-4317

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Dear, R., McGeechan, K., Jenkins, M., Barratt, A., Tattersall, M., Wilcken, N. (2013). Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews, 2013 (12), 1-91. [More Information]
  • Dear, R., Barratt, A., Tattersall, M. (2012). Barriers to recruitment in cancer trials: No longer medical oncologists' attitudes. Medical Journal of Australia, 196(2), 112-113. [More Information]
  • Dear, R., Barratt, A., Evans, A., Simes, R., Newsom, J., Kent, D., Crossing, S., Holliday, C., Segelov, E., Hruby, G., Tattersall, M. (2012). Identifying and prioritising gaps in colorectal cancer trials research in Australia. Medical Journal of Australia, 197(9), 507-511. [More Information]
  • Dear, R., Barratt, A., Askie, L., Butow, P., McGeechan, K., Crossing, S., Currow, D., Tattersall, M. (2012). Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Annals of Oncology, 23(7), 1912-1918. [More Information]
  • Dear, R., Kelly, P., Wright, G., Stalley, P., McCaughan, B., Tattersall, M. (2012). Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia-Pacific Journal of Clinical Oncology, 8(3), 292-302. [More Information]
  • Dear, R., Barratt, A., Askie, L., McGeechan, K., Arora, S., Crossing, S., Currow, D., Tattersall, M. (2011). Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers. Clinical Trials, 8(1), 70-76. [More Information]
  • Dear, R., Barratt, A., Crossing, S., Butow, P., Hanson, S., Tattersall, M. (2011). Consumer input into research: the Australian Cancer Trials website. Health Research Policy and Systems, 9(1), 1-11. [More Information]
  • Dear, R., Tattersall, M., McGeechan, K., Vaughan, M. (2011). Factors associated with Australian and New Zealand oncologists' future work preferences. Asia-Pacific Journal of Clinical Oncology, 7(1), 56-64. [More Information]
  • Dear, R., Barratt, A., McGeechan, K., Askie, L., Simes, R., Tattersall, M. (2011). Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Medical Journal of Australia, 194(8), 387-391. [More Information]
  • Barratt, A., Tattersall, M., McGeechan, K., Dear, R., Wilcken, N. (2010). Combination versus sequential single agent chemotherapy for metastatic breast cancer (Protocol). Cochrane Database of Systematic Reviews, 2010 (10), 1-8. [More Information]
  • Dear, R., Gao, B., Harnett, P. (2010). Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience. Asia-Pacific Journal of Clinical Oncology, 6(1), 66-73. [More Information]
  • Dear, R., Tattersall, M. (2010). Role of pulmonary metastasectomy in osteosarcoma and soft tissue sarcoma. Cancer Forum, 34(3), 1-5.
  • Dear, R., Tattersall, M. (2009). Rediscovering university teaching hospitals for Australia. Medical Journal of Australia, 190(5), 286-286. [More Information]
  • Tattersall, M., Dear, R., Jansen, J., Shepherd, H., Devine, R., Horvath, L., Boyer, M. (2009). Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Medical Journal of Australia, 191(4), 209-212. [More Information]
  • Dear, R., Wilcken, N., Shannon, J. (2008). Beyond chemotherapy: Demystifying the new 'targeted' cancer treatments. Australian Family Physician, 37(1-2), 45-49. [More Information]
  • Wilcken, N., Dear, R. (2008). Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007. European Journal of Cancer, 44(15), 2218-2225. [More Information]
  • Gurney, H., Dear, R. (2007). Obesity in dose calculation: a mouse or an elephant? Journal of Clinical Oncology, 25(30), 4703-4704. [More Information]

2013

  • Dear, R., McGeechan, K., Jenkins, M., Barratt, A., Tattersall, M., Wilcken, N. (2013). Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews, 2013 (12), 1-91. [More Information]

2012

  • Dear, R., Barratt, A., Tattersall, M. (2012). Barriers to recruitment in cancer trials: No longer medical oncologists' attitudes. Medical Journal of Australia, 196(2), 112-113. [More Information]
  • Dear, R., Barratt, A., Evans, A., Simes, R., Newsom, J., Kent, D., Crossing, S., Holliday, C., Segelov, E., Hruby, G., Tattersall, M. (2012). Identifying and prioritising gaps in colorectal cancer trials research in Australia. Medical Journal of Australia, 197(9), 507-511. [More Information]
  • Dear, R., Barratt, A., Askie, L., Butow, P., McGeechan, K., Crossing, S., Currow, D., Tattersall, M. (2012). Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Annals of Oncology, 23(7), 1912-1918. [More Information]
  • Dear, R., Kelly, P., Wright, G., Stalley, P., McCaughan, B., Tattersall, M. (2012). Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia-Pacific Journal of Clinical Oncology, 8(3), 292-302. [More Information]

2011

  • Dear, R., Barratt, A., Askie, L., McGeechan, K., Arora, S., Crossing, S., Currow, D., Tattersall, M. (2011). Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers. Clinical Trials, 8(1), 70-76. [More Information]
  • Dear, R., Barratt, A., Crossing, S., Butow, P., Hanson, S., Tattersall, M. (2011). Consumer input into research: the Australian Cancer Trials website. Health Research Policy and Systems, 9(1), 1-11. [More Information]
  • Dear, R., Tattersall, M., McGeechan, K., Vaughan, M. (2011). Factors associated with Australian and New Zealand oncologists' future work preferences. Asia-Pacific Journal of Clinical Oncology, 7(1), 56-64. [More Information]
  • Dear, R., Barratt, A., McGeechan, K., Askie, L., Simes, R., Tattersall, M. (2011). Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Medical Journal of Australia, 194(8), 387-391. [More Information]

2010

  • Barratt, A., Tattersall, M., McGeechan, K., Dear, R., Wilcken, N. (2010). Combination versus sequential single agent chemotherapy for metastatic breast cancer (Protocol). Cochrane Database of Systematic Reviews, 2010 (10), 1-8. [More Information]
  • Dear, R., Gao, B., Harnett, P. (2010). Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience. Asia-Pacific Journal of Clinical Oncology, 6(1), 66-73. [More Information]
  • Dear, R., Tattersall, M. (2010). Role of pulmonary metastasectomy in osteosarcoma and soft tissue sarcoma. Cancer Forum, 34(3), 1-5.

2009

  • Dear, R., Tattersall, M. (2009). Rediscovering university teaching hospitals for Australia. Medical Journal of Australia, 190(5), 286-286. [More Information]
  • Tattersall, M., Dear, R., Jansen, J., Shepherd, H., Devine, R., Horvath, L., Boyer, M. (2009). Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Medical Journal of Australia, 191(4), 209-212. [More Information]

2008

  • Dear, R., Wilcken, N., Shannon, J. (2008). Beyond chemotherapy: Demystifying the new 'targeted' cancer treatments. Australian Family Physician, 37(1-2), 45-49. [More Information]
  • Wilcken, N., Dear, R. (2008). Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007. European Journal of Cancer, 44(15), 2218-2225. [More Information]

2007

  • Gurney, H., Dear, R. (2007). Obesity in dose calculation: a mouse or an elephant? Journal of Clinical Oncology, 25(30), 4703-4704. [More Information]

To update your profile click here. For support on your academic profile contact .